<DOC>
	<DOCNO>NCT01281579</DOCNO>
	<brief_summary>The purpose study determine blood urine concentration canagliflozin glucose healthy adult volunteer administration single multiple dos canagliflozin .</brief_summary>
	<brief_title>A Single Multiple Dose Study Canagliflozin Healthy Volunteers</brief_title>
	<detailed_description>This open-label ( volunteer study staff know name dose treatment assign ) , single-center study canagliflozin ( JNJ-28431754 ) healthy adult volunteer . Canagliflozin ( sodium-glucose cotransporter 2-inhibitor ) currently development low blood sugar level patient Type 2 diabetes mellitus ( T2DM ) . Healthy volunteer take canagliflozin 50 mg , 100 mg , 300 mg tablet , orally ( mouth ) , daily Day 1 Days 4 9 . All study drug administration occur approximately time morning 240 mL noncarbonated water follow standardize breakfast within 10 minute .</detailed_description>
	<mesh_term>Canagliflozin</mesh_term>
	<criteria>Healthy volunteer body mass index ( BMI , measure person 's weight relation height ) 18 30 kg/m2 , inclusive , body weight less 50 kg History current clinically significant medical illness determine Investigator History clinically significant allergy , especially know hypersensitivity intolerance drug lactose Known allergy canagliflozin excipients formulation canagliflozin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Canagliflozin</keyword>
</DOC>